High-definition non-invasive brain stimulation for word-finding problems after chronic traumatic brain injury
Official title: Using High Definition Transcranial Direct Current Stimulation to Treat Verbal Retrieval Deficits Secondary to Chronic Traumatic Brain Injury (STIM-CTBI)
Run by Beth Israel Deaconess Medical Center · NCT06848140 · Data updated 2026-11-12
This trial tries short sessions of non-invasive high-definition transcranial direct current stimulation (HD-tDCS) to see if they help adults with long-term traumatic brain injury who have trouble finding words and remembering things.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 14 (estimated) |
| Sponsor | Beth Israel Deaconess Medical Center Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | October 1, 2025 |
| Main results expected | April 30, 2028 |
| Study ends | April 30, 2028 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT06848140 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking adults aged 18–85 with a non-military chronic TBI (injury >1 year) who have confirmed verbal retrieval difficulties and can attend in-person visits and MRI.
✕Probably not a fit
People with recent TBI (<1 year), major active neurologic or psychiatric disorders, current substance use disorder, severe sensory or motor impairments, significant cardiac conditions, or contraindications to brain stimulation or MRI are unlikely to qualify or benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults (18–85) with chronic TBI and verified word-finding difficulties are randomized in a double-blind crossover design to receive either active then sham HD-tDCS or sham then active. Each phase consists of 10 sessions over two weeks of 1 mA anodal HD-tDCS targeting the pre-supplementary motor area (preSMA) for 20 minutes, with EEG and cognitive testing at baseline, after the tenth session, and at two-month follow-up; MRI is collected at baseline. Primary outcomes focus on verbal retrieval (fluency, naming, verbal learning), with secondary cognitive and EEG measures. Participants and administering staff are blinded to condition to compare active stimulation to sham.
Why it matters
Potential benefit: If successful, this could provide a non-invasive way to improve word-finding and memory in people living with chronic TBI.
How similar studies have gone: Small trials of tDCS for language impairments after stroke or brain injury have shown mixed but sometimes promising results, while rigorous data specifically in chronic TBI remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 85 * Fluent in speaking and reading English * Able to provide informed consent * Has a TBI at least one year prior to enrollment and not related to military experience * Has a confirmation of verbal retrieval difficulties as measured by the Verbal Retrieval Difficulty Interview questions Exclusion Criteria: * Lifetime major or active neurologic conditions (e.g., stroke, epilepsy, brain tumor, dementia, seizure occurrence less than one year ago) * Lifetime major or active cardiovascular conditions (e.g., cardiac arrythmia, heart failure, heart attack) * Current substance use disorder * Lifetime major psychiatric disorders (e.g., schizophrenia, bipolar disorder) * Severe depression at the time of enrollment (BDI-II \>= 29) or psychiatric ER visits or hospitalization less than 6 months ago prior to enrollment * Current sensory (e.g., blind, deaf) or physical (e.g., severe motor weakness) impairment that interferes with testing * Contraindications for tDCS or MRI * The person cannot be left alone for 8+ hours. * Not verbally communicative. * Currently undergoing and not wishing to discontinue speech and cognitive therapy during study participation. * Incapable of understanding the consent or unable to consent for oneself. * Unable to travel to BIDMC's Berenson-Allen Center * Pregnancy
Where it's running
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Hsueh-Sheng Chiang, MD, PhD — Beth Israel Deaconess Medical Center
- Study coordinator: Iris Hall, BS
- Email: ihall1@bidmc.harvard.edu
- Phone: 617-667-0289
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing Ceriter Stride-One smart insoles with GRAIL gait measurements
We will test whether Ceriter Stride-One pressure-sensitive insoles give the same gait measurements as the GRAIL system for people with stroke, incomplete spinal cord injury, or acquired/traumatic brain injury who can walk independently for at least six minutes.
-
Caregivers and patients with severe brain injury: using the SAFE scale to monitor behavior together
A caregiver-friendly tool called the SAFE scale is tested to see if involving family members in daily observations helps care teams track DoC patients more consistently.
-
PIONEER-Prognosis: Using biomarkers and wearables to forecast recovery after mild traumatic brain injury
This study tests whether blood biomarkers, health data from records, and wearables can help predict how people recover after a mild traumatic brain injury treated in the emergency department.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Depth Electrode Monitoring after Traumatic Brain Injury
This study tests adding a depth electrode with continuous brain monitoring during external ventricular drain placement in adults with traumatic brain injury to see if cortical reverberation signals can be tracked safely.
-
Understanding growth hormone deficiency after a brain injury in adults
This observational study tests whether growth hormone deficiency affects quality of life and symptoms in adults with traumatic brain injury and whether GH replacement helps after 12 weeks.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.